The Case for Biomarker Testing in Gastroesophageal Cancer

To take advantage of the latest targeted therapies in gastroesophageal cancer, physicians needed to identify patients who will benefit, but biomarker testing in this population continued to lag.
Medscape Medical News

source https://www.medscape.com/viewarticle/case-biomarker-testing-gastroesophageal-cancer-2024a10001ko?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost